
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Ask anyone infected with herpes if there's an upside to the sexually transmitted disease, and you're likely to get an incredulous look. But scientists at the Wistar Institute Vaccine Center report in the journal Nature Medicine that the herpes virus may actually hold the key to developing effective vaccines against HIV, cervical cancer, hepatitis, and other viral diseases. A herpes protein, called glycoprotein D, has been shown to help prompt a stronger immune system response to inactivated or weakened viruses in preventive vaccines. Including the protein in a preventive shot, the researchers say, could enhance the vaccine's protection against the targeted ailment. 'The problem with HIV vaccines is that they might look good in mice and primates, but comparable doses in humans are too toxic,' lead researcher Hildegund C.J. Ertl says. 'If you lower the dose to avoid toxic side effects, you don't get the immune response you need.' She believes that using glycoprotein D may solve that problem.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video